Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P070008/S172

Edora 8 HF-T QP 407137 Edora 8 HF-T 407138 Evity 8 HF-T QP 407139 Evity 8 HF-T 407140 Enitra 8 HF-T QP 407141 Enitra 8 H

Biotronik, Inc. · Decision date Sep 25, 2026

MEDTECHLEDGER EXPLANATIONP070008/S172

What did the FDA approve?

The supplied record shows FDA decision APPR on 2026-09-25 for supplement S172 to PMA P070008, filed by Biotronik, Inc. under product code NKE, implantable CRT-P pulse generator. The supplement is on the Normal 180 Day Track, with the stated reason "Change Design/Components/Specifications/Material." Because the identifier P070008 ties this supplement to the original PMA, it is a change to that approved device, not a new approval of the whole system.

The only stated purpose is "the next generation of the Home Monitoring Service Center (HMSC)." The record does not specify which design, component, specification or material changed, nor how HMSC relates to the listed CRT-P generators, so those details are absent. The purpose statement is a reported intent, not independent proof of safety or clinical effectiveness, and the record carries no new indication or trial information.

The decision field shows APPR with no stated approval order or conditions. Device category, specialty and applicant come from the database fields; the record does not identify manufacturing sites or the supplement's document contents.

FDA approval order statement

the next generation of the Home Monitoring Service Center (HMSC)
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Sep 25, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P070008/S172
Regulatory pathway
PMA supplement
Product code
NKE
Decision code
APPR
Decision date
Sep 25, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pulse generator, pacemaker, implantable, with cardiac resynchronization (CRT-P).

Product code
NKE
FDA device class
3

For the original device and its historical approval scope, see PMA P070008. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P070008 · Original PMA

    STRATOS LV CRT-P AND STRATOS LV-T CRT-P, COROX OTW BP LEAD AND COROX OTW-S BP LEAD

  2. P070008/S172 received

    Application receipt date recorded by FDA.

  3. P070008/S172 · FDA decision

    Normal 180 Day Track

  4. P070008/S182 · Related supplement

    Edora 8 HF-T QP Edora 8 HF-T Evity 8 HF-T QP Evity 8 HF-T Enitra 8 HF-T QP Enitra 8 HF-T Enticos 8 HF-T QP Enticos 8 HF-

  5. P070008/S181 · Related supplement

    Edora 8 HF-T QP 407137; Edora 8 HF-T 407138; Evity 8 HF-T QP 407139; Evity 8 HF-T 407140; Enitra 8 HF-T QP 407141; Enitr

  6. P070008/S183 · Related supplement

    Edora 8 HF-T QP, Edora 8 HF-T, Evity 8 HF-T QP, Evity 8 HF-T, Enitra 8 HF-T QP, Enitra 8 HF-T

  7. P070008/S184 · Related supplement

    Sentus ProMRI OTW QP S-75, Sentus ProMRI OTW QP S-85, Sentus ProMRI OTW QP S-95, Sentus ProMRI OTW QP L-75, Sentus ProMR

Timeline entries are records held by MedtechLedger for P070008. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P070008

Explore the linked device profile

Other records with product code NKE

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6024 Jean Rd., Lake Oswego, OR, 97035

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records